AN2 Therapeutics (ANTX) EPS (Diluted) (2021 - 2026)
Powered by 
Analysis
AN2 Therapeutics (ANTX) EPS (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.15 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | AN2 Therapeutics | 262.30 Mn | 262.30 Mn | - | -0.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | -0.35 |
| Dec 31, 2024 | -0.25 |
| Sep 30, 2024 | -0.43 |
| Jun 30, 2024 | -0.48 |
| Mar 31, 2024 | -0.56 |
| Dec 31, 2023 | -0.72 |
| Sep 30, 2023 | -0.65 |
| Jun 30, 2023 | -0.81 |
| Mar 31, 2023 | -0.79 |
| Dec 31, 2022 | -0.77 |
| Sep 30, 2022 | -0.59 |
| Jun 30, 2022 | -0.53 |
| Mar 31, 2022 | -2.98 |
| Dec 31, 2021 | -3.59 |
| Sep 30, 2021 | -3.35 |